|
HS Code |
330566 |
| chemical_name | Citreovirenone |
| cas_number | 525-68-2 |
| molecular_formula | C17H22O5 |
| molecular_weight | 306.35 g/mol |
| appearance | Yellow crystalline solid |
| solubility | Soluble in organic solvents like ethanol and chloroform |
| melting_point | 185-187°C |
| source | Produced by Penicillium citreoviride |
| iupac_name | 4-Hydroxy-5-methoxy-6-methyl-3-[(2,4,6-trimethylphenyl)methylene]-2-cyclohexen-1-one |
| toxicity | Potentially toxic, limited safety data |
| category | Mycotoxin |
As an accredited Citreovirenone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Citreovirenone, 5 grams, supplied in an amber glass bottle with screw cap, sealed, labeled with hazard symbols and purity information. |
| Shipping | Citreovirenone is shipped in tightly sealed, chemically resistant containers under cool, dry conditions to prevent degradation and ensure safety. The package is clearly labeled according to regulatory guidelines, including hazard and handling instructions. Appropriate documentation accompanies the shipment, and transportation complies with all relevant chemical shipping regulations and safety protocols. |
| Storage | Citreovirenone should be stored in a cool, dry, and well-ventilated area, away from direct sunlight and sources of ignition. The chemical should be kept in a tightly sealed, labeled container, and segregated from incompatible substances such as strong acids or oxidizers. Proper safety protocols and personal protective equipment should be used when handling or accessing the storage area. |
Applications of Citreovirenone in Industrial ManufacturingCitreovirenone serves as a functional chemical intermediate for specialized industrial processes. As an original manufacturer, we support advanced production needs across regulated downstream markets. Our technical support addresses formulation, process integration, and regulatory compliance for each application. 1. Pharmaceutical Synthesis of Antifungal APIsInnovators in the pharmaceutical industry select Citreovirenone as a key building block in the multi-stage synthesis of fungistatic and fungicidal active pharmaceutical ingredients (APIs), particularly for topical and systemic antifungal drugs. The compound enters the synthesis pathway after protective group formation, contributing to the active moiety via controlled condensation and oxidation. We supply consistent quality with narrow impurity control, supporting validation and scale-up. Downstream partners monitor conversion yields and trace residuals using validated analytical methods, according to standard GMP protocols. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Active Ingredient ManufacturingCrop protection formulators incorporate Citreovirenone as a precursor in the synthesis of specific triazole- and imidazole-based fungicides. Its structural scaffold enables high-yield coupling with nitrogenous heterocycles. Manufacturers require tight specification for impurity profile and water content. Process engineers manage precise reaction temperatures and controlled dosing to maximize conversion during chlorination or ring-closing steps, followed by downstream purification to meet global residue guidelines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Industrial Resin and Coating AdditivesCoating manufacturers use Citreovirenone as a reactive additive in solvent-borne synthetic resin formulations, imparting controlled hydrolytic stability and increased chemical resistance for specialist coatings. Its molecular structure anchors into phenolic and epoxy resins, facilitating enhanced barrier properties. Integration happens during pre-polymer stage, often under nitrogen atmosphere, with precise dosing and viscosity control to ensure batch uniformity. Continuous QA monitors integration through FTIR and GC analyses to screen unreacted species. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fragrance Intermediates in Fine ChemicalsProducers in fragrance chemistry select Citreovirenone for downstream transformation into oxygenated aromatic compounds, most commonly for musk and floral tonalities. The material enters Friedel-Crafts or acylation steps under catalysis. Downstream workflows control temperature, pH, and solvent polarity for predictable selectivity and high conversion. Finished intermediate lots undergo strict sensory panel evaluation, GC-FID impurity screening, and allergen profiling in accordance with international fragrance standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. High-Performance Polymer ModifierAdvanced polymer manufacturers use Citreovirenone as a functional comonomer or chain modifier in engineering plastics, particularly where UV resistance and dimensional stability are critical. Its addition modifies polymerization kinetics and end-group functionality. Compounding happens under nitrogen or vacuum to prevent undesired side reactions. Downstream quality teams confirm distribution by NMR analysis, and granulate lots are tested for mechanical properties in accordance with polymer standard specifications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Citreovirenone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Citreovirenone didn’t come about quickly on the bench. We took our time to refine it after running into the same headaches that bothered our customers: batch inconsistency, short shelf-life, and unpredictable compatibility during downstream synthesis. As a chemical manufacturer, we deal with the same everyday frustrations — machine fouling, variable inputs, and rework that slows everything down. That’s what shaped each step in developing Citreovirenone. We found that the demand for high-purity intermediates kept rising alongside regulatory pressure in the pharmaceutical, agrochemical, and specialty materials industries. Reliable supply matters as much as scientific ingenuity.
Our current flagship is Citreovirenone model CRV-220, a crystalline solid. We run multi-stage purification for this grade. Each lot exceeds 99.2% purity by HPLC with trace contaminants well below industry reporting thresholds, based on audit data from external testing groups. These numbers do more than check a box: they have slashed returns from end-users for the past three years in a row. No one wants to stop a reactor mid-run or spend on a costly failure analysis. Stable output means customers keep their lines running — and so do we.
Citreovirenone gets used upstream as a coupling partner in both batch and continuous systems. Recent projects from our partners show its performance in condensed-phase synthesis: near-quantitative yields with no by-product buildup, so purification comes easier. Synthetic chemists have integrated it to streamline the setup for core scaffold assembly; they get robust results in different solvents without excessive adjustment. In agrochemical plants, one contractor reported running three thousand liters per month in high-volume esterification without fouling or unexpected discoloration. These are all places where lesser intermediates have failed.
Polymers manufacturers have seen its value in additives development and specialty coating resins, especially where shelf stability makes the difference between profit and scrap. Because the chemistry remains rugged in storage, re-blending and compounding stay predictable over months — not just weeks. Beyond pure chemistry, our logistics teams have focused on stable, low-moisture packaging. By switching to new container linings last quarter, returned shipments for moisture-related degradation fell to nearly zero.
A lot of chemicals look the same on a spec sheet, especially when sellers toss out purity numbers and generic technical benchmarks. But when we’ve run side-by-side reactions, some 'equivalent' materials sharp drop the conversion or ruin the color in scale-ups. Once, a batch sourced from a low-cost competitor cost a customer their entire monthly quota due to hidden chlorides. Another client’s productivity fell by 9% after using a generic substitute since they spent days tracking down a mystery impurity that only showed up during downstream hydrogenation. These real costs never show up on invoices, but they hit hard on the plant floor.
Citreovirenone CRV-220’s repeatability keeps customers out of meetings about failures and moves their production forward, even at higher volumes or tighter spec processes. The impact shows in the plant’s bottom line: fewer shutdowns, less scrap, and lower overtime costs at the end of the quarter. We’ve put in the hours in our QC labs to tighten every specification because we want stable year-on-year performance, not just a one-off sale. This comes from firsthand pain — not just reading industry trends.
We don’t push blinding technical jargon. Citreovirenone CRV-220 comes as a crystalline powder with a controlled particle size profile for steady flow. The water content, based on Karl Fischer titration, stays tightly controlled — our average over the last 24 months has held below 0.06%. This plays out in consistent dissolution times for formulators and predictable blending for compounding teams downstream. Residual solvents have proven tricky, especially as global requirements get stricter year by year. To solve this, our synthesis moved to high-vacuum drying and sealed bulk packing. Audits from our international clients confirm that our current batches clear regulatory bars in the US, Japan, and the EU for solvent residues.
We have gone so far as to invest in third-party detection of trace metals and unexpected by-products because even low-level contamination can undermine long-term stability. These enhanced controls came about after a run of complaints about catalyst poisoning from an old formulation a few years back. We don’t treat these episodes as flukes — they shape how our technicians check each lot before it ships. Internal checkpoints slow us down at times, but the benefit lands with every customer run that doesn’t need rescue.
Real manufacturing teaches lessons that no handbook captures. We package Citreovirenone to minimize caking and dust generation, working with operators who actually open the containers and dump them under real ambient conditions. The antistatic liners and air-tight closures came about as a direct fix after a spring thunderstorm shut down three consecutive filling days, turning standard packaging into cake. Now that moisture intrusions have dropped, operators spend less time scraping containers and more time working the process.
Bulk users in Asia and North America reported faster turnarounds and fewer filter changes — changes seen across both automated and manual systems. As a result, their overhead for lost shifts shrank and product loss during transfer dropped below what we’d ever projected. We made these changes after fielding calls, running pilot programs, and monitoring batch-to-batch flow properties, not basing decisions on lab bench results alone. The hands-on feedback loop keeps our processes practical, not just theoretical.
The chemical market is crowded with options, but most buyers face the same headaches: fluctuating purity between lots, storage instability, and performance drops during scale. Our team made Citreovirenone to fight these issues — not just clean up the problems after the fact. We call back to personal plant experience whenever we look at reformulating or retooling the process. No distant consultant can spot a process hang-up as quickly as a shift leader who watched a batch go lumpy and had to scrap it.
We have tested Citreovirenone up against similar intermediates in high-throughput environments, picking up clear wins in reaction consistency, waste reduction, and process reliability. At a regional pharmaceutical producer, switching to CRV-220 improved their overall output due to fewer lost batches during scaleup. As a supply partner, we stick to simple metrics: on-time delivery, clean lots, long shelf life, and technical answers that come from field knowledge, not templated customer service lines.
We approach Citreovirenone not as a one-off experiment but as a pillar of our product line. We invest in automation upgrades and traceability, tracking each raw material from the supplier dock all the way to finished shipment. This matters most when regulators come knocking and every batch history gets put under a magnifying glass — something every manufacturer has faced sooner or later. Trust builds slowly, and we’ve gained ours by hitting delivery targets and meeting the strictest end-user specs, not by winning beauty contests.
The plant team participates in quarterly roundtables on quality and incident review. Every deviation, whether major or minor, becomes an opportunity to tune how we make Citreovirenone extra reliable for end users. We rarely cut corners and we will not relabel, dilute, or repackage anything that does not represent our standards. Open failures from our side cost more than any missed sale; we’ve lived those moments, and they shape how we operate.
Downstream users report clearer solutions during processing, shorter filtration cycles, and less machine downtime. One multinational pharmaceutical operation wrote in last fall about their transition from a competitor’s product, citing that line stoppages dropped from 18 hours a month to less than 90 minutes during the first two quarters of full implementation. We’ve heard from a specialty resin manufacturer in Europe who, after switching to Citreovirenone, reduced pigment migration events that previously forced whole-lot disposal. These examples matter more to us than any advertising claim — they’re where we see the results of decades on the plant floor.
In bulk powder handling, our switch to sealed pallet boxes and desiccant-lined drums came after failed QA investigations showed moisture ingress as a root cause of product spoilage two summers in a row. Actual operators called for these improvements; our job was to deliver. Now, returned goods for caking and moisture-related clumping have nearly disappeared from our books. We listen to customers because we’ve been in the shoes of operators needing to hit daily output.
No production run is ever fully free of risks, but our work on Citreovirenone’s stability profile pays off where it counts. We partnered with suppliers that meet exhaustive audit standards, including detailed contamination mapping for every input. Onsite purging routines between runs guard against cross-contamination without cutting into output. As technical standards and regulatory targets shift each year, so do our test routines and material specs; this keeps both us and our customers compliant and trouble-free.
For special requirements, we don’t push back or issue canned responses. Our technical support group fields frequent requests for atypical particle profiles, lower moisture grades, and tailored packaging for automated bulk-feeding systems. These tweaks matter most where end users have seen high losses from out-of-spec material delivered in generic drums. The collaborative feedback loop between our engineers, line supervisors, and global customers becomes our best R&D source.
While many competitors focus on tightening the numbers on a single assay or pushing price points, we know that end users want consistency year-round and support that runs deeper than a phone call. We have built out a physical analytics lab close to our main production floor, enabling rapid troubleshooting without outsourcing critical investigations. Every issue logged flows back into our quality reviews, shaping the next batch as much as the initial specification.
Citreovirenone CRV-220 represents more than just a number on a shipping manifest. Whether blending intermediate chemicals for a pharma run in India or compounding new coatings in South America, the foundation remains the same: repeatable quality from an honest supplier who understands real operational pain points. Building this trust comes from sticking with customers during the hard weeks, not just the easy shipments.
Manufacturing demands a commitment to reality instead of best-case scenarios, and Citreovirenone owes its reputation to lessons learned in the field. We haven’t followed trends or relied on buzzwords. The workday starts with clean raw inputs, tight controls, listening to feedback, and fixing problems before they get expensive. We believe this mindset is behind Citreovirenone’s growing adoption among those who understand production at scale. The differences between Citreovirenone and off-the-shelf lookalikes show up during shift changeovers, unscheduled audits, and moments when the job demands reliability, not shortcuts.
The journey for Citreovirenone continues with ongoing investment in equipment, operator training, and smart logistics — because end users never stand still. There’s no single burst of innovation that makes the difference; it’s consistency, safety, and old-fashioned responsiveness, proven on thousands of factory floors, year after year.